David Avigan, MD
Beth Israel Deaconess Medical Center
17
15
8
N/A
0
17
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+24 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (17)
Showing 10 of 17 trials
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Joseph Antin, MD
Dana-Farber Cancer Institute
Shared therapeutic areas:
Worked with same sponsors:
Katarzyna Jamieson, M.D.
University of Florida
Shared therapeutic areas:
Worked with same sponsors:
Edward Ball, M.D.
University of California, San Diego
Shared therapeutic areas:
Worked with same sponsors:
Elizabeth J Shpall, MD
MD Anderson Cancer Research Center
Shared therapeutic areas:
Worked with same sponsors:
Karen K. Ballen, MD
Massachusetts General Hospital
Shared therapeutic areas:
Worked with same sponsors:
Philip McCarthy, M.D.
Roswell Park Cancer Institute
Shared therapeutic areas:
Worked with same sponsors:
Ram Kamble, MD
Baylor College of Medicine
Shared therapeutic areas:
Worked with same sponsors:
Colleen Delaney, MD
Fred Hutchinson Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Richard Maziarz, M.D.
Oregon Health and Science University
Shared therapeutic areas:
Worked with same sponsors:
Frank Haluska, MD, PhD
Massachusetts General Hospital
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (17)
Showing 17 of 17 trials
Adoptive T Cell Therapy With DC/AML Fusion Vaccine Plus Decitabine and Venetoclax in AML
A Phase 1 Study of Vaccination With Dendritic Cell (DC)/Multiple Myeloma (MM) Fusions in Combination With Elranatamab in Relapsed or Refractory Multiple Myeloma
A Phase I/II Trial of the MUC1 Inhibitor, GO-203-2C in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Vaccination of Patients With Ovarian Cancer With Dendritic Cell/Tumor Fusions With Granulocyte Macrophage Colony-stimulating Factor (GM-CSF) and Imiquimod
Interleukin-12 in Treating Women With Metastatic Breast Cancer Who Have Received High-Dose Chemotherapy and Peripheral Stem Cell Transplantation
Chemotherapy and Peripheral Stem Cell Transplantation Followed by Trastuzumab in Treating Women With Metastatic Breast Cancer
Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma
Study of Parathyroid Hormone Following Sequential Cord Blood Transplantation From an Unrelated Donor
Vaccination of Patients With Renal Cell Cancer With Dendritic Cell Tumor Fusions and GM-CSF
Vaccination With Dendritic Cell/Tumor Fusions With Autologous Stem Cell Transplants in Patients With Multiple Myeloma
The Use of Dendritic Cell/Tumor Fusions as a Novel Tumor Vaccine in Patients With Multiple Myeloma
Vaccination of Patients With Breast Cancer With Dendritic Cell/Tumor Fusions and IL-12
A Phase I/II Study to Assess the Safety and Efficacy of Vaccinations With Allogeneic Dendritic Cells: Autologous Tumor-Derived Cells Subjected to Electrofusions in Patients With AJCC Stage IV Renal Cell Carcinoma
The Use of Dendritic Cell/Tumor Hybridomas as a Novel Tumor Vaccine in Patients With Advance Melanoma
Primary Tumor Harvest for the Purpose of Possible Use in a Future Clinical Trial in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Blockade of PD-1 in Conjunction With the Dendritic Cell/Myeloma Vaccines Following Stem Cell Transplantation
PD-1 Alone or With Dendritic Cell/Renal Cell Carcinoma Fusion Cell Vaccine
All 17 trials loaded